Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CYCLACEL PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 25.72 M 58.75 M 54.00 M 13.81 M 22.92 M
    Net Receivables 1.53 M 2.47 M 105,000.00 375,000.00 755,000.00
    Total Inventories 508,000.00 213,000.00 0.00 0.00 0.00
    Progress Payments & Others 213,000.00 0.00 0.00 0.00
    Prepaid Expenses 1.02 M 1.74 M 1.37 M
    Other Current Assets 237,000.00 603,000.00 2.69 M 2.84 M 4.09 M
    Current Assets Total 29.01 M 63.78 M 58.16 M 17.03 M 27.76 M
    Long Term Receivables 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 0.00 241,000.00 0.00 0.00
    Property, Plant & Equipment Net 1.75 M 3.02 M 2.12 M 2.04 M 3.41 M
    Property, Plant & Equipment Gross 9.84 M 13.11 M 11.10 M 9.07 M 10.02 M
    Accumulated Depreciation 8.09 M 10.10 M 8.98 M 7.03 M 6.60 M
    Other Assets 195,000.00 9.12 M 2.75 M 0.00 0.00
    Deferred Charges 0.00 0.00 0.00 0.00 0.00
    Tangible Other Assets 195,000.00 196,000.00 0.00 0.00 0.00
    Intangible Other Assets 8.92 M 2.75 M 0.00 0.00
    Total Assets 30.96 M 75.91 M 63.28 M 19.07 M 31.18 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 10,000.00 89,000.00 251,000.00 793,000.00
    Accrued Payroll
    Income Taxes Payable
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 7.87 M 9.74 M 5.66 M 12.46 M 3.53 M
    Current Liabilities Total 8.63 M 14.71 M 7.92 M 14.87 M 6.86 M
    Long Term Debt 0.00 0.00 0.00 78,000.00 368,000.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 1.06 M 2.09 M 1.44 M 0.00 0.00
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 626,000.00 1.14 M 0.00 0.00 0.00
    Total Liabilities 10.32 M 17.94 M 9.36 M 14.95 M 7.22 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00
    Preferred Stock 20.67 M 20.67 M 20.67 M 210.95 M 223.62 M
    Common Equity -31,000.00 37.30 M 33.25 M -206.84 M -199.66 M
    Common Stock 20,000.00 20,000.00 16,000.00 2,000.00 2,000.00
    Capital Surplus 202.71 M 202.24 M 174.04 M -94.86 M -107.52 M
    Revaluation Reserves
    Other Appropriated Reserves -42,000.00 -2.63 M -2.54 M
    Unappropriated (Free) Reserves
    Retained Earnings -202.72 M -162.33 M -138.28 M
    Equity in Untaxed Reserves
    ESOP Guarantees
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 -2.96 M -1.17 M
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 -109.02 M -90.97 M
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 30.96 M 75.91 M 63.28 M 19.07 M 31.18 M
    Common Shares Outstanding 20.43 M 20.43 M 16.16 M 1.87 M 1.87 M